The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies

Endocrine Reviews

Volumn 19, Issue 6, 1998, Pages 673-716

  Rapoport, Basil ^a   Chazenbalk, Gregorio D ^c   Jaume, Juan Carlos ^b   Mclachlan, Sandra M ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PROTIRELIN RECEPTOR; THYROTROPIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN ANTIBODY REACTION; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN;

EID: 0032247323     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.19.6.673     Document Type: Article

References (399)

1. Parmentier M, Libert F, Maenhaut C, Lefort Gerard C, Perret J, Van Sande J, Dumont JE, Vassart G 1989 Molecular cloning of the thyrotropin receptor. Science 246:1620-1622
2. Nagayama Y, Kaufman KD, Seto P, Rapoport B 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165: 1184-1190
3. Libert F, Lefort A, Gerard C, Parmentier M, Perret J, Ludgate M, Dumont JE, Vassart G 1989 Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun 165:1250-1255
4. Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantel A, Milgrom E 1990 Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 166:394-403
5. Frazier AL, Robbins LS, Stork PJ, Sprengel R, Segaloff DL, Cone RD 1990 Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol Endocrinol 90:1264-1276
6. Akamizu T, Ikuyama S, Saji M, Kosugi S, Kozak C, McBride OW, Kohn LD 1990 Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc Natl Acad Sci USA 87:5677-5681
7. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ 1992 Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267:1430-1433
8. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
9. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle M-J, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401
10. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G 1995 Genetic basis of endocrine disease: somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585
11. Russo D, Arturi F, Chiefari E, Filetti S 1997 Molecular insights into TSH receptor abnormality and thyroid disease. J Endocrinol Invest 20:36-47
12. Gross B, Misrahi M, Sar S, Milgrom E 1991 Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun 177:679-687
13. Nagayama Y, Rapoport B 1992 The thyrotropin receptor twenty five years after its discovery: new insights after its molecular cloning. Mol Endocrinol 6:145-156
14. Nagayama Y, Nagataki S 1994 The thyrotropin receptor: its gene expression and structure-function relationships. Thyroid Today 17:1-9
15. Libert F, Parmentier M, Maenhaut C, Lefort A, Gerard C, Perret J, Van Sande J, Dumont JE, Vassart G 1990 Molecular cloning of a dog thyrotropin (TSH) receptor variant. Mol Cell Endocrinol 68:R15-R17
16. Kobe B, Deisenhofer J 1993 Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366: 751-756
17. Kajava AV, Vassart G, Wodak SJ 1995 Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 3:867-877
18. McQuade R, Thomas Jr CG, Nayfeh SN 1986 Covalent crosslinking of thyrotropin to thyroid plasma membrane receptors: subunit composition of the thyrotropin receptor. Arch Biochem Biophys 246:52-62
19. Buckland PR, Rickards CR, Howells RD, Jones ED, Rees Smith B 1982 Photo-affinity labelling of the thyrotropin receptor. FEBS Lett 145:245-249
20. Kajita Y, Rickards CR, Buckland PR, Howells RD, Rees Smith B 1985 Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem J 227:413-420
21. Gennick SE, Thomas Jr CG, Nayfeh SN 1987 Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line. Endocrinology 121:2119-2130
22. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Seto P, Rapoport B 1991 A new structural model for the thyrotropin (TSH) receptor as determined by covalent crosslinking of TSH to the recombinant receptor in intact cells: evidence for a single polypeptide chain. Mol Endocrinol 5:1607-1612
23. Russo D, Nagayama Y, Chazenbalk GD, Wadsworth HL, Rapoport B 1992 Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor. Endocrinology 130:2135-2138
24. 5 cells. FEBS Lett 215:316-322
25. Endo T, Ikeda M, Ohmori M, Anzai E, Haraguchi K, Onaya T 1992 Single subunit structure of the human thyrotropin receptor. Biochem Biophys Res Commun 187:887-893
26. Ban T, Kosugi S, Kohn LD 1992 Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wild-type receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. Endocrinology 131:815-829
27. Loosfelt H, Pichon C, Jolivet A, Misrahi M, Caillou B, Jamous M, Vannier B, Milgrom E 1992 Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci USA 89:3765-3769
28. Misrahi M, Ghinea N, Sar S, Saunier B, Jolivet A, Loosfelt H, Cerutti M, Devauchelle G, Milgrom E 1994 Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur J Biochem 222:711-719
29. Fiedler K, Simons K 1995 The role of N-Glycans in the secretory pathway. Cell 81:309-312
30. Chazenbalk GD, Tanaka K, Nagayama Y, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B 1997 Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology 138:2893-2899
31. Graves PN, Vlase H, Bobovnikova Y, Davies TF 1996 Multimeric complex formation by the thyrotropin receptor in solubilized thyroid membranes. Endocrinology 137:3915-3920
32. Chazenbalk GD, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B 1996 Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 137:4586-4591
33. Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, Rapoport B 1991 Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for TSH receptor function. Proc Natl Acad Sci USA 88:902-905
34. Wadsworth HL, Chazenbalk GD, Nagayama Y, Russo D, Rapoport B 1990 An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science 249:1423-1425
35. Couet J, Sar S, Jolivet A, Vu Hai M-T, Milgrom E, Misrahi M 1996 Shedding of human thyrotropin receptor ectodomain: involvement of a matrix metalloprotease. J Biol Chem 271:4545-4552
36. Hunt N, Willey KP, Jahner D, Ivell R, Northemann W, Castel MA, Leidenberger F 1992 Multiple forms of thyroid stimulating hormone receptor associated with Graves' disease. Exp Clin Endocrinol 100:22-27
37. Murakami M, Miyashita K, Yamada M, Iriuchijima T, Mori M 1992 Characterization of human thyrotropin receptor-related peptide-like immunoreactivity in peripheral blood of Graves' disease. Biochem Biophys Res Commun 186:1074-1080
38. Couet J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, Misrahi M 1996 Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35:14800-14805
39. Seglen PO, Bohley P 1992 Autophagy and other vacuolar protein degradation mechanisms. Experientia 48:158-172
40. Takai O, Desai RK, Seetharamaiah GS, Jones CA, Allaway GP, Akamizu T, Kohn LD, Prabhakar BS 1991 Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides. Biochem Biophys Res Commun 179:319-326
41. Kosugi S, Akamizu T, Takai O, Prabhakar BS, Kohn LD 1991 The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Thyroid 1:321-330
42. Chazenbalk GD, Rapoport B 1994 Cleavage of the thyrotropin receptor does not occur at a classical subtilisin-related proprotein covertase endoproteolytic site. J Biol Chem 269:32209-32213
43. Kakinuma A, Chazenbalk GD, Tanaka K, Nagayama Y, McLachlan SM, Rapoport B 1997 An N-linked glycosylation motif from the non-cleaving luteinizing hormone receptor substituted for the homologous region (Gly-367 to Glu-369) of the thyrotropin receptor prevents cleavage at its second, downstream site. J Biol Chem 272:28296-28300
44. Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B 1998 Thyrotropin receptor cleavage at site 1 does not involve a specific amino acid motif but instead depends on the presence of the unique, 50 amino acid insertion. J Biol Chem 273:1959-1963
45. Shakin-Eshleman SH, Spitalnik SL, Kasturi L 1996 The amino acid at the x position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency. J Biol Chem 271:6363-6366
46. Davis DP, Rozell TG, Liu X, Segaloff DL 1997 The six N-linked carbohydrates of the lutropin/chorionogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol Endocrinol 11:550-562
47. Vu TK, Hung DT, Wheaton VI, Coughlin SR 1991 Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068
48. Barr PJ 1991 Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66:1-3
49. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K 1994 Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557
50. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J 1996 Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 271:11376-11382
51. Kojro E, Fahrenholz F 1995 Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J Biol Chem 270:6476-6481
52. Black RA, Durie FH, Otten-Evans C, Miller R, Slack JL, Lynch DH, Castner B, Mohler KM, Gerhart M, Johnson RS, Itoh Y, Okada Y, Nagase H 1996 Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. Biochem Biophys Res Commun 225:400-405
53. Tanaka K, Nagayama Y, Yamasaki H, Hayashi H, Namba H, Yamashita S, Niwa M 1996 Epitope-tagging of a functional thyrotropin receptor: detection of the native receptor on intact cells. Biochem Biophys Res Commun 228:21-28
54. Kosugi S, Ban T, Akamizu T, Kohn LD 1991 Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J Biol Chem 266:19413-19418
55. Johnstone AP, Cridland JC, DaCosta CR, Harfst E, Shepherd PS 1994 Monoclonal antibodies that recognize the native human thyrotropin receptor. Mol Cell Endocrinol 105:R1-R9
56. Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G, Dumont JE 1996 Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 119:161-168
57. Kohn LD, Shimura H, Shimura Y, Hidaka A, Giuliani C, Napolitano G, Ohmori M, Laglia G, Saji M 1995 The thyrotropin receptor. Vitam Horm 50:287-384
58. Rees Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121
59. Chazenbalk GD, McLachlan SM, Nagayama Y, Rapoport B 1996 Is receptor cleavage into two subunits necessary for thyrotropin action? Biochem Biophys Res Commun 225:479-484
60. Nagayama Y, Rapoport B 1992 Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Endocrinology 131:548-552
61. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont J, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409:469-474
62. Kopp P, Muirhead S, Jourdain N, Gu W-X, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (Serine281-Isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639
63. Van Sande J, Swillens S, Gerard C, Allgeier A, Massart C, Vassart G, Dumont J 1995 In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence. Eur J Biochem 229:338-343
64. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G 1995 Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 9:725-733
65. Kosugi S, Mori T 1995 TSH receptor and LH receptor, 1995. Endocrine J 42:587-606
66. Zhang M-L, Sugawa H, Kosugi S, Mori T 1995 Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Commun 211:205-210
67. Mikol DD, Gulcher JR, Stefansson K 1990 The oligodendrocytemyelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol 110:471-479
68. Kosugi S, Ban T, Akamizu T, Kohn LD 1992 Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies. Biochem Biophys Res Commun 189:1754-1762
69. Wadsworth HL, Russo D, Nagayama Y, Chazenbalk GD, Rapoport B 1992 Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol Endocrinol 6:394-398
70. Tate RL, Holmes JM, Kohn LD, Winand RJ 1975 Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes. J Biol Chem 250:6527-6533
71. Drummond RW, McQuade R, Grunwald R, Thomas Jr CG, Nayfeh SN 1982 Separation of two thyrotropin binding components from porcine thyroid tissue by affinity chromatography: characterization of high and low affinity sites. Proc Natl Acad Sci USA 79:2202-2207
72. Iida Y, Konishi J, Kasagi K, Endo K, Misaki T, Kuma K, Torizuka K 1983 Partial purification and properties of the TSH receptors from human thyroid plasma membranes. Acta Endocrinol (Copenh) 103:198-204
73. Kress BC, Spiro RG 1986 Studies on the glycoprotein nature of the thyrotropin receptor: interaction with lectins and purification of the bovine protein with the use of Bandeiraea (Griffonia) simplicifolia I affinity chromatography. Endocrinology 118:974-979
74. Chazenbalk GD, Jaume JC, McLachlan SM, Rapoport B 1997 Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem 272:18959-18965
75. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Rapoport B 1991 Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor. Mol Endocrinol 5:29-33
76. Amino N, Watanabe Y, Tamaki H, Iwatani Y, Miyai K 1987 In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies. Clin Endocrinol (Oxf) 27:615-624
77. Graves PN, Vlase H, Davies TF 1995 Folding of the recombinant human thyrotropin (TSH) receptor extracellular domain: identification of folded monomeric and tetrameric complexes that bind TSH receptor autoantibodies. Endocrinology 136:521-527
78. Vlase H, Graves PN, Magnusson RP, Davies TF 1995 Human autoantibodies to the thyrotropin receptor: recognition of linear, folded, and glycosylated recombinant extracellular domain. J Clin Endocrinol Metab 80:46-53
79. Chazenbalk GD, Rapoport B 1995 Expression of the extracellular region of the thyrotropin receptor in a baculovirus vector using a promoter active earlier than the polyhedrin promoter: implications for the expression of functional, highly glycosylated proteins. J Biol Chem 270:1543-1549
80. Koizumi Y, Zakarija M, McKenzie JM 1982 Solubilization, purification, and partial characterization of thyrotropin receptor from bovine and human thyroid glands. Endocrinology 110:1381-1391
81. Akamizu T, Mori T, Ishii H, Yotota T, Nakamura H, Imura H 1988 Purification of TSH receptor from porcine thyroid membrane and effect of various protease inhibitors on receptor stability. Endocrinol Jpn 35:275-283
82. Foti D, Kaufman KD, Chazenbalk GD, Rapoport B 1990 Generation of a biologically-active, secreted form of human thyroid peroxidase by site-directed mutagenesis. Mol Endocrinol 4:786-791
83. Kaufman KD, Foti D, Seto P, Rapoport B 1991 Overexpression of an immunologically-intact, secreted form of human thyroid peroxidase in eukaryotic cells. Mol Cell Endocrinol 78:107-114
84. Harfst E, Johnstone AP, Nussey SS 1992 Characterization of the extracellular region of the human thyrotropin receptor expressed as a recombinant protein. J Mol Endocrinol 9:227-236
85. Huang GC, Collison KS, McGregor AM, Banga JP 1992 Expression of a human thyrotropin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves' disease. J Mol Endocrinol 8:137-144
86. Costagliola S, Alcalde L, Ruf J, Vassart G, Ludgate M 1994 Overexpression of the extracellular domain of the thyrotrophin receptor in bacteria; production of thyrotrophin-binding inhibiting immunoglobulins. J Mol Endocrinol 13:11-21
87. Hunt N, Willey KP, Abend N, Northemann W, Leidenberger F 1996 Epitope mapping of a recombinant human TSH receptor extracellular domain: identification of a predominant epitope using animal sera. J Clin Lab Anal 10:193-204
88. Bobovnikova Y, Graves PN, Vlase H, Davies TF 1997 Characterization of soluble, disulfide bond-stabilized, prokaryotically expressed human thyrotropin receptor ectodomain. Endocrinology 138:588-593
89. Pelham HR, Jackson RJ 1976 An efficient mRNA-dependent translation system from reticulocytes. Eur J Biochem 67:247-256
90. Akamizu T, Kosugi S, Kohn LD 1990 Thyrotropin receptor processing and interaction with thyrotropin. Biochem Biophys Res Commun 169:947-952
91. Burch HB, Nagy EV, Kain KC, Lanar DE, Carr FE, Wartofsky L, Burman KD 1993 Expression polymerase chain reaction for the in vitro synthesis and epitope mapping of autoantigen. Application to the human thyrotropin receptor. J Immunol Methods 158:123-130
92. Morgenthaler NG, Tremble J, Huang G, Scherbaum WA, McGregor AM, Banga JP 1996 Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. J Clin Endocrinol Metab 81:700-706
93. Prentice L, Sanders JF, Perez M, Kato R, Sawicki J, Oda Y, Jaskolski D, Furmaniak J, Rees Smith B 1997 Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system. J Clin Endocrinol Metab 82:1288-1292
94. Summers MD, Smith GE 1987 A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Texas A&M University, College Station, TX, pp 1-56
95. Harfst E, Johnstone AP, Gout I, Taylor AH, Waterfield MD, Nussey SS 1992 The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotropin receptor. Mol Cell Endocrinol 83:117-123
96. Huang GC, Page MJ, Nicholson LB, Collison KS, McGregor AM, Banga JP 1993 The thyrotropin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. J Mol Endocrinol 10:127-142
97. Seetharamaiah GS, Desai RK, Dallas JS, Tahara K, Kohn LD, Prabhakar BS 1993 Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. Autoimmunity 14:315-320
98. Seetharamaiah GS, Kurosky A, Desai RK, Dallas JS, Prabhakar BS 1994 A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. Endocrinology 134:549-554
99. Fan J, Seetharamaiah GS, Desai RK, Dallas JS, Wagle NM, Prabhakar BS 1993 Analysis of autoantibody reactivity in patients with Graves' disease using recombinant extracellular domain of the human thyrotropin receptor and synthetic peptides. Autoimmunity 15:285-291
100. Seetharamaiah GS, Dallas JS, Patibandla SA, Thotakura NR, Prabhakar BS 1997 Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera. J Immunol 158:2798-2804
101. Harfst E, Johnstone AP, Nussey SS 1992 Interaction of thyrotropin and thyroid stimulating antibodies with recombinant extracellular region of the TSH receptor. Lancet 339:193-194
102. De Forteza R, Smith CU, Amin J, McKenzie JM, Zakarija M 1994 Visualization of the thyrotropin receptor on the cell surface by potent autoantibodies. J Clin Endocrinol Metab 78:1271-1273
103. Jaume JC, Kakinuma A, Chazenbalk GD, Rapoport B, McLachlan SM 1997 TSH receptor autoantibodies in serum are present at much lower concentrations than thyroid peroxidase autoantibodies: analysis by flow cytometry. J Clin Endocrinol Metab 82:500-507
104. Zakarija M 1983 Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J Clin Lab Immunol 10:77-85
105. Knight J, Laing P, Knight A, Adams D, Ling N 1986 Thyroid stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory. J Clin Endocrinol Metab 62:342-347
106. Williams Jr RC, Marshall NJ, Kilpatrick K, Montano J, Brickell PM, Goodall M, Ealey PA, Shine B, Weetman AP, Craig RK 1988 Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simulataneous analysis of C lambda gene polymorphisms. J lin Invest 82:1306-1312
107. McLachlan SM, Rapoport B 1992 The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 13:192-206
108. Vlase H, Matsuoka N, Graves PN, Magnusson RP, Davies TF 1997 Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain. Endocrinology 138:1658-1666
109. Jarvis DL, Summers MD, Garcia Jr A, Bohlmeyer DA 1993 Influence of different signal peptides and prosequences on expression and secretion of human tissue plasminogen activator in the baculovirus system. J Biol Chem 268:16754-16762
110. Rapoport B, McLachlan SM, Kakinuma A, Chazenbalk GD 1996 Critical relationship between autoantibody recognition and TSH receptor maturation as reflected in the acquisition of mature carbohydrate. J Clin Endocrinol Metab 81:2525-2533
111. Okamoto Y, Hayashi Y, DeGroot LJ 1995 Expression of human thyrotropin receptor by recombinant adenovirus. Thyroid 5:51-53
112. Park JY, Kim IJ, Lee MH, Seo JK, Suh PG, Cho BY, Ryu SH, Chae C-B 1997 Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries. Endocrinology 138:617-626
113. Minich WB, Behr M, Loos U 1997 Expression of a functional tagged human thyrotropin receptor in HeLa cells using recombinant vaccinia virus. Exp Clin Endocrinol Diabetes 105:282-290
114. Perret J, Ludgate M, Libert F, Gerard C, Dumont JE, Vassart G, Parmentier M 1990 Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun 171:1044-1050
115. Endo T, Ohmori M, Ikeda M, Anzai E, Onaya T 1992 Heterogeneous responses of recombinant human thyrotropin receptor to immunoglobulins from patients with Graves' disease. Biochem Biophys Res Commun 186:1391-1396
116. Matsuba T, Yamada M, Suzuki H, Kanai A, Isozaki O, Yoshida T, Tsushima T, Yasukawa K 1995 Expression of recombinant human thyrotropin receptor in myeloma cells. J Biochem 118:265-270
117. Murakami M, Miyashita K, Kakizaki S, Saito S, Yamada M, Iriuchijima T, Takeuchi T, Mori M 1995 Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors. Eur J Endocrinol 133:80-86
118. Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K, Koh C-S 1996 Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to anti-thyroid drug treatment. J Clin Endocrinol Metab 81:1758-1767
119. Ludgate M, Perret J, Parmentier M, Gerard C, Libert F, Dumont JE, Vassart G 1990 Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies. Mol Cell Endocrinol 73:R13-R18
120. Vitti P, Elisei R, Tonacchera M, Chiovato L, Mancusi F, Rago T, Mammoli C, Ludgate M, Vassart G, Pinchera A 1993 Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab 76:499-503
121. Filetti S, Foti D, Costante G, Rapoport B 1991 Recombinant human TSH receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies. J Clin Endocrinol Metab 72:1096-1101
122. Costagliola S, Swillens S, Niccoli P, Dumont JE, Vassart G, Ludgate M 1992 Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein. J Clin Endocrinol Metab 75:1540-1544
123. Kakinuma A, Chazenbalk G, Filetti S, McLachlan SM, Rapoport B 1996 Both the 5′ and 3′ non-coding regions of the thyrotropin receptor messenger RNA influence the level of receptor protein expression in transfected mammalian cells. Endocrinology 137: 2664-2669
124. Chazenbalk GD, Nagayama Y, Kaufman KD, Rapoport B 1990 The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor. Endocrinology 127:1240-1244
125. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF, Lefkowitz RJ 1995 Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature 374:272-276
126. Seetharamaiah GS, Wagle NM, Morris JC, Prabhakar BS 1995 Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology 136:2817-2824
127. Nicholson LB, Vlase H, Graves P, Nilsson M, Molne J, Huang GC, Morgenthaler NG, Davies TF, McGregor AM, Banga JP 1996 Monoclonal antibodies to the human thyrotropin receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells. J Mol Endocrinol 16:159-170
128. Tsai-Morris CH, Buczko E, Wang W, Dufau ML 1990 Intronic nature of the rat luteinizing hormone receptor gene defines a soluble receptor subspecies with hormone binding activity. J Biol Chem 265:19385-19388
129. VuHai-LuuThi MT, Misrahi M, Houllier A, Jolivet A, Milgrom E 1992 Variant forms of the pig lutropin/choriogonadotropin receptor. Biochemistry 31:8377-8383
130. Takeshita A, Nagayama Y, Fujiyama K, Yokoyama N, Namba H, Yamashita S, Izumi M, Nagataki S 1992 Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript. Biochem Biophys Res Commun 188: 1214-1219
131. Graves PN, Tomer Y, Davies TF 1992 Cloning and sequencing of a 1.3 kb variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun 187:1135-1143
132. Shi Y, Zou M, Parhar RS, Farid NR 1993 High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells. Thyroid 3:129-133
133. Osuga Y, Kudo M, Kaipia A, Kobilka B, Hsueh AJW 1997 Derivation of functional antagonists using N-terminal extracellular domain of gonadotropin and thyrotropin receptors. Mol Endocrinol 11:1659-1668
134. 133a. Da Costa CR, Johnstone AP 1998 Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies. J Biol Chem 273:11874-11880
135. 133b. Costagliola S, Khoo D, Duprez L, Vassart G Efficient binding of TSH and TSAbs to the aminoterminal domain of the TSH receptor inserted in the plasma membrane by a glycan phosphatidylinositol anchor (GPI). Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998 (Abstract P3-106)
136. 133c. Osuga Y, Liang SG, Dallas JS, Wang C, Hsueh AJ 1998 Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients. Endocrinology 139:671-676
137. Nagayama Y, Russo D, Chazenbalk GD, Wadsworth HL, Rapoport B 1990 Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. Biochem Biophys Res Commun 173:1150-1156
138. Nagayama Y, Takeshita A, Luo W, Ashizawa K, Yokoyama N, Nagataki S 1994 High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain. Thyroid 4:155-159
139. Rees Smith B, Hall R 1974 Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 2:427-431
140. Mehdi SQ, Nussey SS 1975 A radio-ligand receptor assay for the long-acting thyroid stimulator. Biochem J 145:105-111
141. Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD, Rapoport B 1991 Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest 88:336-340
142. Tahara K, Ban T, Minegishi T, Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 179:70-77
143. Segaloff DL, Ascoli M 1993 The lutropin/choriogonadotropin receptor . . . 4 years later. Endocr Rev 14:324-347
144. Vlase H, Matsuoka N, Graves PN, Magnusson RP, Davies TF 1997 Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain. Endocrinology 138:1658-1666
145. Morris JC, Bergert ER, McCormick DJ 1993 Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem 268:10900-10905
146. Bryant WP, Bergert ER, Morris JC 1994 Delineation of amino acid residues within hTSHr 256-275 that participate in hormone binding. J Biol Chem 269:30935-30938
147. Haraguchi K, Saito T, Endo T, Onaya T 1994 Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding. Life Sci 55:961-968
148. Kaneshige M, Haraguchi K, Endo T, Anzai E, Onaya T 1995 The functional significance of the second extracellular loop of thyrotropin receptor in thyrotropin- and thyroid stimulating antibody-dependent signal transduction. Horm Metab Res 27:267-271
149. Kosugi S, Mori T 1994 The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction. FEBS Lett 349:89-92
150. Thomas DM, Segaloff DL 1994 Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells. Endocrinology 135:1902-1912
151. Rozell TG, Wang H, Liu X, Segaloff DL 1995 Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/ choriogonadotropin receptor. Mol Endocrinol 9:1727-1736
152. Morris JC, Gibson JL, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS 1994 Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity 17:287-299
153. Smith BR 1970 The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro. J Endocrinol 46:45-54
154. Dirmikis S, Munro DS 1973 Studies on the binding activity for the long-acting thyroid stimulator. J Endocrinol 58:577-590
155. Davies Jones E, Rees Smith B 1984 A water-soluble fragment of the thyroid-stimulating hormone receptor which binds both thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies. J Endocrinol 100:113-118
156. Foti D, Russo D, Costante G, Filetti S 1991 The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin. J Clin Endocrinol Metab 73:710-716
157. Davies DR, Padlan EA, Sheriff S 1990 Antibody-antigen complexes. Annu Rev Biochem 59:439-473
158. Laver WG, Air GM, Webster RG, Smith-Gill SJ 1990 Epitopes on protein antigens: misconceptions and realities. Cell 61:553-556
159. Libert F, Ludgate M, Dinsart C, Vassart G 1991 Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector. J Clin Endocrinol Metab 73:857-860
160. Yamamoto M, Rapoport B 1978 Studies on the binding of radio-labeled thyrotropin to cultured human thyroid cells. Endocrinology 103:2011-2019
161. Bryant WP, Bergert ER, Morris JC 1995 Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity 22:69-79
162. Prabhakar BS, Fan J, Seetharamaiah GS 1997 Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity. Immunol Today 18:437-442
163. Pekonen F, Weintraub BD 1979 Thyrotropin receptors on bovine thyroid membranes: two types with different affinities and specificities. Endocrinology 105:352-359
164. Kohn LD, Aloj SM, Tombaccini D, Rotella CM, Toccafondi R, Marcocci C, Corda D, Grollman EF 1985 The thyrotropin receptor. In: Biochemical Actions of Hormones. Academic Press, Inc., New York, vol 12:457-512
165. Nagayama Y, Russo D, Wadsworth HL, Chazenbalk GD, Rapoport B 1991 Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem 266:14926-14930
166. Kosugi S, Ban T, Akamizu T, Kohn LD 1991 Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. Biochem Biophys Res Commun 180: 1118-1124
167. Kosugi S, Ban T, Kohn LD 1993 Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Mol Endocrinol 7:114-130
168. Kosugi S, Ban T, Akamizu T, Kohn LD 1992 Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol 6:168-180
169. Akamizu T, Inoue D, Kosugi S, Kohn LD, Mori T 1994 Further studies of amino acids (268-304) in thyrotropin (TSH)-lutropin/ chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure. Thyroid 4:43-48
170. Nagayama Y, Rapoport B 1992 Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab 75:1425-1430
171. Yamashita K, Field JB 1970 Preparation of thyroid plasma membranes containing a TSH-responsive adenyl cyclase. Biochem Biophys Res Commun 40:171-178
172. Wolff J, Jones AB 1971 The purification of bovine thyroid plasma membranes and the properties of membrane-bound adenyl cyclase. J Biol Chem 246:3939-3947
173. Orgiazzi J, Williams DE, Chopra IJ, Solomon DH 1976 Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J Clin Endocrinol Metab 42:341-354
174. Endo K, Kasagi K, Konishi J, Ikekubo K, Tatsuyo O, Takeda Y, Mori T, Torizuka K 1978 Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 46:734-739
175. Ohmori M, Endo T, Onaya T 1991 Development of chicken antibodies toward the human thyrotropin receptor peptides and their bioactivities. Biochem Biophys Res Commun 174:399-403
176. Endo T, Ohmori M, Ikeda M, Onaya T 1991 Thyroid stimulating activity of rabbit antibodies toward the human thyrotropin receptor peptide. Biochem Biophys Res Commun 177:145-150
177. Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K, Cho BY 1997 Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications. J Clin Endocrinol Metab 82:1953-1959
178. Adams DD, Purves HD 1956 Abnormal responses in the assay of thyrotropins. Proc Univ Otago Sch Med 34:11-12
179. Meek JC, Jones AE, Lewis UJ, Vanderlaan WP 1964 Characterization of the long-acting thyroid stimulator of Graves' disease. Proc Natl Acad Sci USA 52:342-349
180. Kriss JP, Pleshakov V, Chien JR 1964 Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J Clin Endocrinol Metab 24:1005-1028
181. Pastan I, Roth J, Macchia V 1966 Binding of hormone to tissue: the first step in polypeptide hormone action. Proc Natl Acad Sci USA 56:1802-1809
182. Manley SW, Bourke JR, Hawker RW 1972 Reversible binding of labelled and non-labelled thyrotrophin by intact thyroid tissue in vitro. J Endocrinol 55:555-563
183. Amir SM, Carraway Jr TF, Kohn LD 1973 The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem 248:4092-4100
184. Lissitzky S, Fayet G, Verrier B, Hennen G, Jaquet P 1973 Thyroid-stimulating hormone binding to cultured thyroid cells. FEBS Lett 29:20-24
185. Moore WV, Wolff J 1974 Thyroid-stimulating hormone binding to beef thyroid membranes. J Biol Chem 249:6255-6263
186. Kotani M, Kariya T, Field JB 1975 Studies of thyroid-stimulating hormone binding to bovine thyroid plasma membranes. Metabolism 24:959-971
187. Kaneko T, Zor U, Field JB 1970 Stimulation of thyroid adenyl cyclase activity and cyclic adenosine 3′5′-monophosphate by long-acting thyroid stimulator. Metabolism 19:430-438
188. Levey GS, Pastan I 1970 Activation of thyroid adenyl cyclase by long-acting thyroid stimulator. Life Sci 9:67-73
189. Smith BR, Hall R 1974 Binding of thyroid stimulators to thyroid membranes. FEBS Lett 42:301-304
190. Matsuura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Endo K, Kojima K, Wataya K 1980 Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med 303:738-741
191. Drexhage HA, Bottazzo GF, Doniach D, Bitensky L, Chayen J 1980 Evidence for thyroid-growth-stimulating immunoglobulins in some goitrous thyroid diseases. Lancet 2:287-292
192. Yavin E, Yavin Z, Schneider MD, Kohn LD 1981 Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. Proc Natl Acad Sci USA 78:3180-3184
193. Dumont JE, Roger PP, Ludgate M 1987 Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts and misconceptions. Endocr Rev 8:448-452
194. Zakarija M, Jin S, McKenzie JM 1988 Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells. J Clin Invest 81:879-884
195. Drexhage HA 1996 Autoimmunity and thyroid growth. Where do we stand? Eur J Endocrinol 135:39-45
196. Adams DD 1958 The presence of an abnormal thyroid stimulator in the serum of some thyrotoxic patients. J Clin Endocrinol 18: 699-712
197. McKenzie JM 1958 The bioassay of thyrotropin in serum. Endocrinology 63:372-382
198. McKenzie JM 1958 Delayed thyroid response to serum from thyrotoxic patients. Endocrinology 62:865-868
199. Adams DD, Kennedy TH 1967 Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocrinol Metab 27:173-177
200. Shishiba Y, Shimizu T, Yoshimura S, Shizumi K 1973 Direct evidence for human thyroidal stimulation by LATS-protector. J Clin Endocrinol Metab 36:517-521
201. Adams DD, Fastier FN, Howie JB, Kennedy TH, Kilpatrick JA, Stewart RD 1974 Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocrinol Metab 39: 826-832
202. Onaya T, Kotani K, Yamada T, Ochi Y 1973 New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. J Clin Endocrinol Metab 36:859-866
203. Rapoport B 1976 Dog thyroid cells in monolayer tissue culture: adenosine 3′,5′-cyclic monophosphate response to thyrotropic hormone. Endocrinology 98:1189-1197
204. Rapoport B, Adams RJ 1978 Bioassay of TSH using dog thyroid cells in monolayer culture. Metabolism 27:1732-1742
205. Toccafondi R, Aterini S, Medici MA, Rotella CM, Tanini A, Zonefrati R 1980 Thyroid-stimulating antibody (TSAb) detected in sera of Graves' patients using human thyroid cell cultures. Clin Exp Immunol 40:532-539
206. Hinds WE, Takai N, Rapoport B, Filetti S, Clark OH 1981 Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab 52:1204-1210
207. Kasagi K, Konishi J, Iida Y, Ikekubo K, Mori T, Kuma K, Torizuka K 1982 A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3′,5′-monophosphate increase. J Clin Endocrinol Metab 54:108-114
208. Chopra IJ, Solomon DH, Limberg NP 1970 Specific and non-specific responses in the bioassay of long-acting thyroid stimulator (LATS). J Clin Endocrinol Metab 31:382-390
209. Ambesi-Impiombato FS, Parks LAM, Coon HG 1980 Culture of hormone dependent epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459
210. Vitti P, Rotella CM, Valente WA, Cohen J, Aloj SM, Laccetti P, Ambesi-Impiombato FS, Grollman EF, Pinchera A, Toccafondi R, Kohn LD 1983 Characterization of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3′,5′-monophosphate production in FRTL-5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab 57:782-791
211. McKenzie JM, Zakarija M 1989 Clinical Review 3: The clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 69:1093-1096
212. Michelangeli VP, Munro DS, Poon CW, Frauman AG, Colman PG 1994 Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JP09 cells), compared with an assay using FRTL-5 cells. Clin Endocrinol (Oxf) 40:645-652
213. Konishi J, Iida Y, Endo K, Misaki T, Nohara Y, Matsuura N, Mori T, Torizuka K 1983 Inhibition of thyrotropin-induced adenosine 3′5′-monophosphate increase by immunoglobulins from patients with primary myxedema. J Clin Endocrinol Metab 57:544-549
214. Takasu N, Mori T, Koizumi Y, Takeuchi S, Yamada T 1984 Transient neonatal hypothyroidism due to maternal immunoglobulins that inhibit thyrotropin-binding and post-receptor processes. J Clin Endocrinol Metab 59:142-146
215. Chiovato L, Vitti P, Lombardi A, Lopez G, Santini F, Macchia E, Fenzi GF, Mammoli C, Battiato S, Pinchera A 1987 Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells. J Endocrinol Invest 10:383-388
216. Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N 1997 Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. Thyroid 7:13-19
217. Rees Smith B, Hall R 1981 Measurement of thyrotropin receptor antibodies. Methods Enzymol 74:405-420
218. Shewring GA, Rees Smith B 1982 An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 17:409-417
219. Kasagi K, Hatabu H, Tokuda Y, Aral K, Iida Y, Konishi J 1988 Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases. Acta Endocrinol (Copenh) 117: 365-372
220. Kakinuma A, Chazenbalk GD, Jaume JC, Rapoport B, McLachlan SM 1997 The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies. J Clin Endocrinol Metab 82:2129-2134
221. Rapoport B, Takai NA, Filetti S 1982 Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue. J Clin Endocrinol Metab 54:1059-1062
222. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE, Weintraub BD 1996 Engineering human glycoprotein hormone superactive analogues. Nat Biotech 14:1257-1263
223. Heyma P, Harrison LC 1984 Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. J Clin Invest 74:1090-1097
224. Rapoport B, Seto P, Magnusson RP 1984 Immunoprecipitation of radiolabeled human thyroid cell proteins by serum from patients with autoimmune thyroid disease. Endocrinology 115:2137-2144
225. Huang GC, Page MJ, Roberts AJ, Malik AN, Spence H, McGregor AM, Banga JP 1990 Molecular cloning of a human thyrotropin receptor cDNA fragment. FEBS Lett 264:193-197
226. McLachlan SM, Rapoport B 1993 Recombinant thyroid autoantigens: the keys to the pathogenesis of autoimmune thyroid disease. J Intern Med 234:347-359
227. Beever K, Bradbury J, Phillips D, McLachlan SM, Pegg C, Goral A, Overbeck W, Feifel G, Rees Smith B 1989 Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 35:1949-1954
228. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams Jr RC, Shine B, Marshall NJ 1990 Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86:723-727
229. Tokuda Y, Kasagi K, Iida Y, Hatabu H, Misaki T, Arai K, Endo K, Konishi J 1988 Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. J Clin Endocrinol Metab 67:251-258
230. Desai RK, Dallas JS, Gupta MK, Seetharamaiah GS, Fan J, Tahara K, Kohn LD, Prabhakar BS 1993 Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides. J Clin Endocrinol Metab 77:658-663
231. Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS 1996 Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3′,5′-monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology 137:3329-3339
232. Yamaguchi K, Shimojo N, Kikuoka S, Hoshioka A, Hirai A, Tahara K, Kohn LD, Kohno Y, Niimi H 1997 Genetic control of anti-thyrotropin receptor antibody generation in H-2 k mice immunized with thyrotropin receptor-transfected fibroblasts. J Clin Endocrinol Metab 82:4266-4269
233. Kohn LD, Suzuki K, Hoffman WH, Tombaccini D, Marcocci C, Shimojo N, Watanabe Y, Amino N, Cho BY, Kohno Y, Hirai A, Tahara K 1997 Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 82:3998-4009
234. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin repector and a class II molecule. Proc Natl Acad Sci USA 93:11074-11079
235. Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M 1996 Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134:97-103
236. Jaume JC, Prummel MF, Wiersinga WM, McLachlan SM, Rapoport B 1993 Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex and ophthalmopathy. Thyroid 3:291-295
237. Rapoport B, Portolano S, McLachlan SM 1995 Combinatorial immunoglobulin gene libraries: new insights into human organ-specific autoantibodies. Immunol Today 16:43-49
238. McLachlan SM, Rapoport B 1995 Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response. Clin Exp Immunol 101:200-206
239. Chacko S, Padlan E, Portolano S, McLachlan SM, Rapoport B 1996 Structural studies of human autoantibodies. Crystal structure of a thyroid peroxidase autoantibody Fab. J Biol Chem 271:12191-12198
240. Davidson HW, Watts C 1989 Epitope-directed processing of specific antigen by B lymphocytes. J Cell Biol 109:85-92
241. Guo J, Quaratino S, Jaume JC, Costante G, Londei M, McLachlan SM, Rapoport B 1996 Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by a recombinant human autoantibody Fab converted to IgE. J Immunol Methods 195:81-92
242. Marion S, Ropars A, Ludgate M, Braun JM, Charreire J 1992 Characterization of monoclonal antibodies to the human thyrotropin receptor. Endocrinology 130:967-975
243. Hill BL, Erlanger BF 1988 Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Endocrinology 122:2840-2850
244. Costagliola S, Ruf J, Durand-Gorde M-J, Carayon P 1991 Monoclonal antiidiotypic antibodies intereact with the 93 kilodalton thyrotropin receptor and exhibit heterogeneous biological activities. Endocrinology 128:1555-1562
245. Taub R, Hsu J-C, Garsky VM, Hill BL, Erlanger BF, Kohn LD 1992 Peptide sequences from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin (TSH) receptor are similar to TSH and inhibit TSH-increased cAMP production in FRTL-5 cells. J Biol Chem 267:5977-5984
246. Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G 1998 Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol 160:1458-1465
247. Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD 1982 Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. Proc Natl Acad Sci USA 79:6680-6684
248. De Bernardo E, Davies TF 1987 A study of human-human hybridomas from patients with autoimmune thyroid disease. J Clin Immunol 7:71-77
249. Yoshida T, Ichikawa Y, Ito K, Homma M 1988 Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogeneous bioactivities. J Biol Chem 263:16341-16347
250. Yokoyama N, Izumi M, Katamine S, Nagataki S 1987 Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection. J Clin Endocrinol Metab 64:215-218
251. Baker JR, Saunders NB, Kaulfersch W, Burman KD 1988 Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. J Immunol 140:2593-2599
252. Shin EK, Akamizu T, Matsuda F, Sugawa H, Fujikura J, Mori T, Honjo T 1994 Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease. J Immunol 152:1485-1492
253. Okuda J, Akamizu T, Sugawa H, Matsuda F, Hua L, Mori T 1994 Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. J Clin Endocrinol Metab 79:1600-1604
254. Fan J, Desai RK, Dallas JS, Wagle NM, Seetharamaiah GS, Prabhakar BS 1994 High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Clin Immunol Immunopathol 71:69-74
255. Morgenthaler NG, Kim MR, Tremble J, Huang GC, Richter W, Gupta M, Scherbaum WA, McGregor AM, Banga JP 1996 Human IgG autoantibodies to the thyrotropin receptor from Epstein Barr virus transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity. J Clin Endocrinol Metab 81:3155-3161
256. Li H, Akamizu T, Okuda J, Sugawa H, Matsuda F, Tsubata T, Mori T 1995 Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. Biochem Biophys Res Commun 207:985-993
257. McLachlan SM, Rapoport B 1996 Editorial: Monoclonal human autoantibodies to the TSH receptor: the holy grail, and why are we looking for it? J Clin Endocrinol Metab 81:3152-3154
258. Costagliola S, Many MC, Stalmans-Falys M, Tonacchera M, Vassart G, Ludgate M 1994 Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. Endocrinology 135:2150-2159
259. Brown RS, Kertiles LP, Reichlin S 1983 Partial purification and characterization of thyrotropin binding inhibitory immunoglobulins from normal human plasma. J Clin Endocrinol Metab 56:156-163
260. Ealey PA, Kohn LD, Ekins RP, Marshall NJ 1984 Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators. J Clin Endocrinol Metab 58:909-914
261. Ealey PA, Valente WA, Ekins RP, Kohn LD, Marshall NJ 1985 Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Endocrinology 116:124-131
262. McLachlan SM, Pegg CAS, Atherton MC, Middleton SM, Clark F, Rees Smith B 1986 TSH receptor antibody synthesis by thyroid lymphocytes. Clin Endocrinol (Oxf) 24:223-230
263. Kendall-Taylor P, Knox AJ, Steel NR, Atkinson S 1984 Evidence that thyroid stimulating antibody is produced within the thyroid gland. Lancet 1:654-656
264. Arqueros MC, Niepomniszcze H, Moreno J 1986 Thyroid glands in patients' with Graves' disease are sources of thyrotropin-binding inhibitory (TBI) activity. Acta Endocrinol (Copenh) 112:351-354
265. Sugenoya A, Kobayashi S, Kasuga Y, Masuda H, Fujimori M, Komatsu M, Takahashi S, Yokoyama S, Shimizu T, Yamada T, Iida F 1997 Evidence of intrathyroidal accumulation of TSH receptor antibody in Graves' disease. Acta Endocrinol (Copenh) 126: 416-418
266. Wilson R, McKillop JH, Pearson C, Burnett AK, Gunn I, McNicol AM, Thomson JA 1988 Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide. Clin Exp Immunol 73:265-268
267. Chou F, Wang PW, Sheen-Chen SM 1994 The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease. J Endocrinol Invest 17:41-44
268. Janeway Jr CA, Travers P 1994 Immunobiology: The Immune System in Health and Disease. Chapter 8. The humoral immune response. Garland Publishing Inc, New York, pp 8.1-8.58
269. Londei M, Bottazzo GF, Feldmann M 1985 Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228:85-89
270. Weetman AP, Volkman DJ, Burman KD, Margolick JB, Petrick P, Weintraub BD, Fauci AS 1986 The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol 39:139-150
271. Grubeck-Loebenstein B, Londei M, Greenall C, Pinch K, Kassal H, Waldhausl W, Feldmann M 1988 Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic goiter and in Graves' disease. J Clin Invest 81:1608-1614
272. Mackenzie WA, Schwartz AE, Friedman EW, Davies TF 1987 Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 64:818-824
273. Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RFL, Rapoport B, Feldmann M 1991 Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA 88:7415-7419
274. Tandon N, Freeman MA, Weetman AP 1992 T cell responses to synthetic TSH receptor peptides in Graves' disease. Clin Exp Immunol 89:468-473
275. Sakata S, Tanaka S, Okuda K, Miura K, Manshouri T, Atassi MZ 1993 Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease. Mol Cell Endocrinol 92:77-82
276. Fan J, Desai RK, Seetharamaiah GS, Dallas JS, Wagle NM, Prabhakar BS 1993 Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides. J Autoimmun 6:799-808
277. Okamoto Y, Yanagawa T, Fisfalen ME, DeGroot LJ 1994 Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptide epitopes of human thyrotropin receptor. Thyroid 4:37-42
278. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD 1995 Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clin Immunol Immunopathol 75:117-124
279. Soliman M, Kaplan E, Yanagawa T, Hidaka Y, Fisfalen ME, DeGroot LJ 1995 T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. J Clin Endocrinol Metab 80:905-914
280. Soliman M, Kaplan E, Abdel-Latif A, Scherberg N, DeGroot LJ 1995 Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases. J Clin Endocrinol Metab 80:2312-2321
281. Soliman M, Kaplan E, Guimaraes V, Yanagawa T, DeGroot LJ 1996 T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in siblings in a family with Graves' disease. Thyroid 6:545-551
282. Akamizu T, Ueda Y, Okuda J, Mori T 1995 Establishment and characterization of an antihuman thyrotropin (TSH) receptor-specific CD4+ T cell line from a patient with Graves' disease: evidence for multiple T cell epitopes on the TSH receptor including the transmembrane domain. Thyroid 5:259-264
283. Fisfalen ME, Palmer EM, van Seventer GA, Soltani K, Sawai Y, Kaplan E, Hidaka Y, Ober C, DeGroot LJ 1997 Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab 82:3655-3663
284. Mullins RJ, Cohen SBA, Webb MC, Chernajovsky Y, Dayan C, Londei M, Feldmann M 1995 Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. J Clin Invest 96:30-37
285. Kellerman S, McCormick DJ, Freeman SL, Morris JC, Conti-Fine BM 1995 TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun 8:685-698
286. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF 1997 Detection of major T-cell epitopes on human TSH receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 82:3361-3366
287. Lanzavecchia A 1993 Identifying strategies for immune intervention. Science 260:937-944
288. Matsuo H, Batocchi A-P, Hawke S, Nicolle M, Jacobson L, Vincent A, Newsom-Davis J, Willcox N 1995 Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J Immunol 155:3683-3692
289. Steinman RM 1991 The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296
290. Farrant J, Bryant AE, Chan J, Himsworth RL 1996 Thyroglobulin-treated blood dendritic cells induce IgG anti-thyroglobulin antibody in vitro in Hashimoto's thyroiditis. Clin Immunol Immunopathol 41:433-442
291. Lanzavecchia A 1990 Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8:773-793
292. Manca F, Fenoglio D, Kunkl A, Cambiaggi C, Sasso M, Celada F 1988 Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. A possible influence of paratype specificity on the mode of antigen processing. J Immunol 140:2893-2898
293. Watts C, Lanzavecchia A 1993 Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 178:1459-1463
294. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C 1995 Modulation of antigen processing by bound antibodies canboost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 181: 1957-1963
295. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1118
296. Mackenzie WA, Davies TF 1987 An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunology 61:101-103
297. Mullins RJ, Chernajovsky Y, Dayan C, Londei M, Feldmann M 1994 Transfection of thyroid autoantigens into EBV-transformed B cell lines. J Immunol 152:5572-5580
298. Martin A, Magnusson RP, Kendler DL, Concepcion E, Ben-Nun A, Davies TF 1993 Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. J Clin Invest 91:1567-1574
299. McIntosh RS, Mulcahy AF, Hales JM, Diamond AG 1993 Use of Epstein-Barr virus-based vectors for expression of thyroid autoantigens in human B-lymphoblastoid cell lines. J Autoimmun 6:353-365
300. Mosmann TR, Coffman RL 1989 TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
301. McLachlan SM, Prummel MF, Rapoport B 1994 Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 78:1070-1074
302. Paschke R, Schuppert F, Taton M, Velu T 1994 Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol 141:309-315
303. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA 1996 Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6:97-106
304. Liblau RS, Singer SM, McDevitt HO 1995 Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38
305. Tomer Y, Davies TF 1993 Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-120
306. Burch HB, Nagy EV, Lukes YG, Cai WY, Wartofsky L, Burman KD 1991 Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis. Biochem Soc Trans 181:498-505
307. Bech K, Larsen JH, Hansen JM, Nerup J 1974 Yersinia enterocolitica and thyroid disorders. Lancet 2:951-952
308. Shenkman L, Bottone EJ 1976 Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med 85:735-739
309. Weiss M, Rubinstein E, Bottone EJ, Shenkman L, Bank H 1979 Yersinia enterocolitica antibodies in thyroid disorders. Isr J Med Sci 15:553-555
310. Lidman K, Eriksson U, Norberg R, Fagraeus A 1976 Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia
311. Weiss M, Ingbar SH, Winblad S, Kasper DL 1983 Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science 219:1331-1333
312. Heyma P, Harrison LC, Robins-Browne R 1986 Thyrotropin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Clin Exp Immunol 64: 249-254
313. Byfield PGH, Davies SC, Copping S, Barclay FE, Borriello SP 1989 Thyrotropin (TSH)-binding proteins in bacteria and their cross-reaction with autoantibodies against the human TSH receptor. J Endocrinol 121:571-577
314. Luo G, Fan J, Seetharamaiah GS, Desai RK, Dallas JS, Wagle N, Doan R, Niesel DW, Klimpel GR, Prabhakar BS 1993 Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J Immunol 151:922-928
315. Wenzel BE, Heesemann J, Wenzel KW, Scriba PC 1988 Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1:56
316. Luo G, Seetharamaiah GS, Niesel DW, Zhang H, Peterson JW, Prabhakar BS, Klimpel GR 1994 Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J Immunol 152:2555-2561
317. Zhang H, Kaur I, Niesel DW, Seetharamaiah GS, Peterson JW, Prabhakar BS, Klimpel GR 1997 Lipoprotein from Yersinia enterocolitica contains epitopes that cross-react with the human thyrotropin receptor. J Immunol 158:1976-1983
318. Arscott P, Rosen ED, Koenig RJ, Kaplan MM, Ellis T, Thompson N, Baker Jr JR 1992 Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 75:295-300
319. Quaratino S, Thorpe CJ, Travers PJ, Londei M 1995 Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc Natl Acad Sci USA 92:10398-10402
320. Lehmann PV, Forsthuber T, Miller A, Sercarz EE 1992 Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157
321. Rose NR, Witebsky E 1956 Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76:417-427
322. Costagliola S, Many MC, Stalmans-Falys M, Vassart G, Ludgate M 1995 The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background. Mol Cell Endocrinol 115:199-206
323. Dallas JS, Desai RK, Cunningham SJ, Morris JC, Seetharamaiah GS, Wagle N, Goldblum RM, Prabhakar BS 1994 Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinology 134:1437-1445
324. Carayanniotis G, Huang GC, Nicholson LB, Scott T, Allain P, McGregor AM, Banga JP 1995 Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Clin Exp Immunol 99:294-302
325. Wagle NM, Patibandla SA, Dallas JS, Morris JC, Prabhakar BS 1995 Thyrotropin receptor-specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass. Endocrinology 136:3461-3469
326. Wagle NM, Dallas JS, Seetharamaiah GS, Fan J, Desai RK, Memar O, Rajaraman S, Prabhakar BS 1994 Induction of hyperthyroxinemia in BALB/C but not in several other strains of mice. Autoimmunity 18:103-112
327. Hidaka Y, Guimaraes V, Soliman M, Yanagawa T, Okamoto Y, Quintans J, DeGroot LJ 1995 Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. Endocrinology 136:1642-1647
328. Costagliola S, Alcalde L, Tonacchera M, Ruf J, Vassart G, Ludgate M 1994 Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. Biochem Biophys Res Commun 199:1027-1034
329. Kong YM 1986 The mouse model of autoimmune thyroid disease. In: McGregor AM (ed) Immunology and Medicine. MTP Press Ltd, Lancaster, UK, pp 1-24
330. Kotani T, Umeki K, Hirai K, Ohtaki S 1990 Experimental murine thyroiditis induced by porcine thyroid peroxidase and its transfer by the antigen-specific T cell line. Clin Exp Immunol 80:11-18
331. Patibandla SA, Gattadahalli S, Seetharamaiah GS, Thotakura NR, Peake RL, Prabhakar BS 1997 Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies. Endocrinology 138: 1559-1566
332. Tang D, DeVit M, Johnston SA 1992 Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154
333. Vladutiu AO 1993 The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 93:1-8
334. Macht L, Fukuma N, Leader K, Sarsero D, Pegg CAS, Phillips DIW, Yates P, McLachlan SM, Elson C, Rees Smith B 1991 Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 84:34-42
335. Davies TF, Kimura H, Fong P, Kendler D, Shultz LD, Thung S, Martin A 1991 The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion. Clin Immunol Immunopathol 60:319-330
336. Martin A, Kimura H, Thung S, Fong P, Shultz LD, Davies TF 1992 Characteristics of long-term human thyroid peroxidase autoantibody secretion in seid mice transplanted with lymphocytes from patients with autoimmune thyroiditis. Int Arch Allergy Immunol 98:317-323
337. Akasu F, Morita T, Resetkova E, Miller N, Akasu R, Jamieson C, Volpe R 1993 Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 76:223-230
338. Morita T, Yoshikawa N, Akasu F, Resetkova E, Arreaza G, Miller N, Jamieson C, Volpe R 1993 Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 77:255-261
339. Saxon A, Macy E, Denis K, Tary-Lehmann M, Witte O, Braun J 1991 Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest 87:658-665
340. Soliman M, Kaplan E, Straus F, Fisfalen ME, Hidaka Y, Guima-raes V, DeGroot LJ 1995 Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 80:2848-2855
341. Yoshikawa N, Nishikawa M, Mori S, Tokoro T, Yamamoto Y, Ikehara S, Kumazawa H, Yamashita T, Inada M 1997 Simultaneous xenotransplantation of human Graves' thyroid tissue and autologous bone marrow cells in severe combined immunodeficient mice: successful reconstitution of human Graves' hyperthyroidism. Eur J Endocrinol 136:213-222
342. Resetkova E, Nishikawa M, Mukuta T, Arreaza G, Fornasier VL, Volpe R 1995 Homing of 51Cr-labeled human peripheral lymphocytes to Graves' thyroid tissue xenografted into SCID mice. Thyroid 4:293-298
343. Mukuta T, Nishikawa M, Arreaza G, Resetkova E, Yoshikawa N, Fornasier VL, Young E, Volpe R 1996 The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary re-xenografts of Graves' thyroid tissue. Thyroid 6:429-436
344. Matsuoka N, Martin A, Concepcion ES, Unger P, Shultz LD, Davies TF 1993 Preservation of functioning human thyroid organoids in the scid mouse: II. Biased use of intrathyroidal T cell receptor V genes. J Clin Endocrinol Metab 77:311-315
345. Loos U, Hagner S, Bohr URM, Bogatkewitsch GS, Jakobs KH, Van Koppen CJ 1995 Enhanced cAMP accumulation by the human thyrotropin receptor variant with the Pro52Thr substitution in the extracellular domain. Eur J Biochem 232:62-65
346. de Roux N, Misrahi M, Brauner R, Houang M, Carel JC, Granier M, Le Bouc Y, Ghinea N, Boumedienne A, Toublanc JE, Milgrom E 1996 Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab 81:4229-4235
347. Clifton-Bligh RJ, Gregory JW, Ludgate M, John R, Persani L, Asteria C, Beck-Peccoz P, Chatterjee VKK 1997 Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab 82:1094-1100
348. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S 1995 Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 332:155-160
349. Biebermann H, Schoneberg T, Krude H, Schultz G, Guderman T, Gruters A 1997 Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 82:3471-3480
350. Bohr URM, Behr M, Loos U 1993 A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochim Biophys Acta 1216: 504-508
351. Bahn RS, Dutton CM, Heufelder AE, Sarkar G 1994 A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 78:256-260
352. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95
353. Sunthornthepvarakul T, Hayashi Y, Refetoff S 1994 Polymorphism of a variant human thyrotropin receptor (hTSHR) gene. Thyroid 4:147-149
354. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33
355. Paschke R, Metcalfe A, Alcalde L, Vassart G, Weetman A, Ludgate M 1994 Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metab 79:1234-1238
356. Solomon DH and Kleeman KE 1976 Concepts in the pathogenesis of Graves' disease. In: Stollerman GH (ed) Advances in Internal Medicine. Year Book Medical Publishers, Inc, Chicago, pp 273-299
357. 3H-labeled pituitary extracts. J Biol Chem 245:967-975
358. 3H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc Natl Acad Sci USA 69:1711-1715
359. Winand RJ, Kohn LD 1975 Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyrotropin and an exophthalmogenic factor derived from thyrotropin. J Biol Chem 250:6522-6526
360. Bolonkin D, Tate RL, Luber JH, Kohn LD, Winand RJ 1975 Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem 250:6516-6521
361. Burch HB, Wartofsky L 1993 Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 14:747-793
362. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi GF 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338
363. Endo T, Ohno M, Kotani S, Gunji K, Onaya T 1993 Thyrotropin receptor in non-thyroid tissue. Biochem Biophys Res Commun 190:774-779
364. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3:297-300
365. Paschke R, Elisei R, Vassart G, Ludgate M 1993 Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle. J Endocrinol Invest 16:329-332
366. Molnar I, Balazs C 1992 TSH binding site structures in human eye muscle fractions identified by using covalent-crosslinking. Biomed Pharmacother 46:121-125
367. Heufelder AE, Bahn RS 1992 Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy. Exp Clin Endocrinol 100:62-67
368. Perros P, Kendall-Taylor P 1994 Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol Invest 17:163-170
369. Mori S, Yoshikawa N, Tokoro T, Ikehara S, Inoue Y, Nishikawa M, Inada M 1996 Studies of retroorbital tissue xenografts from patients with Graves' ophthalmopathy in severe combined immunodeficient (SCID) mice: detection of thyroid-stimulating antibody. Thyroid 6:275-281
370. Paschke R, Vassart G, Ludgate M 1995 Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42:565-569
371. Davies TF 1994 Editorial: The thyrotropin receptors spread themselves around. J Clin Endocrinol Metab 79:1232-1233
372. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M, Marcus C 1995 Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211:426-431
373. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest IV F 1986 Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 7:651-656
374. Peyster RG, Ginsburg F, Silber JH, Adler LP 1986 Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. Am J Neuroradiol 7:35-40
375. Teng CS, Rees Smith B, Anderson J, Hall R 1975 Comparison of thyrotrophin receptors in membranes prepared from fat and thyroid tissue. Biochem Biophys Res Commun 66:836-840
376. Davies TF, Teng CS, McLachlan SM, Smith BR, Hall R 1978 Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol Cell Endocrinol 9:303-310
377. Iida Y, Amir SM, Ingbar SH 1987 Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes. Endocrinology 121:1627-1636
378. Mullin BR, Lee G, Ledley FD, Winand RJ, Kohn LD 1976 Thyrotropin interactions with human fat cell membrane preparations and the finding of a soluble thyrotropin binding component. Biochem Biophys Res Commun 69:55-62
379. Endo T, Ohta K, Haraguchi K, Onaya T 1995 Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J Biol Chem 270:10833-10837
380. Roselli-Rehfuss L, Robbins LS, Cone RD 1992 Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 130:1857-1861
381. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M 1997 Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 82:2003-2005
382. Marcus C, Ehren H, Bolme P, Arner P 1988 Regulation of lipolysis during the neonatal period. Importance of thyrotropin. J Clin Invest 82:1793-1797
383. Janson A, Karlsson FA, Micha-Johannson G, Bolme P, Bronnegard M, Marcus C 1995 Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes. J Clin Endocrinol Metab 80:1712-1716
384. Haraguchi K, Shimura H, Lin L, Saito T, Endo T, Onaya T 1996 Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor. Biochem Biophys Res Commun 223:193-198
385. Haraguchi K, Shimura H, Lin L, Endo T, Onaya T 1996 Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors. Endocrinology 137:3200-3205
386. Ludgate M, Costagliola S, Crisp M, Daunerie C, Boschi A, Neu F, Denef JF, Vassart G, Many MC 1997 Thyrotropin receptor immunoreactivity in the orbits of patients with thyroid associated ophthalmopathy. Thyroid 7 [Suppl 1]:S-104 (Abstract)
387. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE 1998 Thyrotropin receptor expression in Graves' orbital adipose/ connective tissue: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83:998-1002
388. Spitzweg C, Joba W, Hunt N, Heufelder AE 1997 Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur J Endocrinol 136:599-607
389. Atassi MZ, Manshouri T, Sakata S 1991 Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor. Proc Natl Acad Sci USA 88:3613-3617
390. Ohmori M, Endo T, Ikeda M, Onaya T 1991 Role of N-terminal region of the thyrotropin (TSH) receptor in signal transduction for TSH or thyroid stimulating antibody. Biochem Biophys Res Commun 178:733-738
391. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF 1995 Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology 136:4415-4423
392. Ikeda M, Ohmori M, Endo T, Onaya T 1993 Immunodectection of TSH receptor antibodies in sera of patients with autoimmune thyroid disease by ELISA (enzyme-linked immunosorbent assay). Acta Endocrinol (Copenh) 128:126-130
393. Sugawa H, Akamizu T, Kosugi S, Ueda Y, Ohta C, Okuda J, Mori T 1995 Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule. Eur J Endocrinol 133:283-293
394. Murakami M, Mori M 1990 Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease. Biochem Biophys Res Commun 171:512-518
395. Piraphatdist T, Sugawa H, Inoue D, Enomoto T, Mori T, Imura H 1990 Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site. Biochem Biophys Res Commun 172:529-536
396. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris III JC, Burman KD 1992 Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun 188: 28-33
397. Mori T, Sugawa H, Piraphatdist T, Inoue D, Enomoto T, Imura H 1991 A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves' immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSH. Biochem Biophys Res Commun 178:165-172
398. Ueda Y, Sugawa H, Akamizu T, Okuda J, Ueda M, Kosugi S, Ohta C, Kihou Y, Mori T 1995 Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition. Eur J Endocrinol 132:62-68
399. Marion S, Braun JM, Ropars A, Kohn L, Charreire J 1994 Induction of autoimmunity by immunization of mice with human thyrotropin receptor. Cell Immunol 158:329-341